Finding a Covid-19 vaccine – and ultimately resolving the global pandemic – may depend on collaborations like the one recently formed between GlaxoSmithKline (GSK) and Sanofi.

Such partnerships will be “extremely important” moving forward, said GlobalData infectious disease analyst Philipp Rosenbaum, not least because they can bring together new ideas and innovation with experience in the field.

Read the full article here.